cyc 202 has been researched along with cytochrome c-t in 3 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (cytochrome c-t) | Trials (cytochrome c-t) | Recent Studies (post-2010) (cytochrome c-t) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 11,809 | 21 | 5,125 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bravo, R; Bruna, A; Caelles, C; Camarasa, J; Camins, A; Canudas, AM; Escubedo, E; Jiménez, A; Jorda, EG; Pallàs, M; Pubill, D; Verdaguer, E | 1 |
| Almenara, JA; Atadja, P; Craig, R; Dent, P; Grant, S; Maggio, SC; Rosato, RR; Vrana, J | 1 |
| Chaube, SK; Tripathi, A | 1 |
3 other study(ies) available for cyc 202 and cytochrome c-t
| Article | Year |
|---|---|
Neuroprotective action of flavopiridol, a cyclin-dependent kinase inhibitor, in colchicine-induced apoptosis.
Topics: Amino Acid Chloromethyl Ketones; Animals; Animals, Newborn; Anthracenes; Anti-Bacterial Agents; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Bromodeoxyuridine; Carrier Proteins; Caspase 3; Caspases; CDC2-CDC28 Kinases; Cell Count; Cell Survival; Cells, Cultured; Cerebellum; Chromatin; Colchicine; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinases; Cytochromes c; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Flavonoids; Flow Cytometry; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Kainic Acid; MAP Kinase Kinase 4; Microtubules; Minocycline; Mitogen-Activated Protein Kinase Kinases; Neurons; Neuroprotective Agents; Piperidines; Purines; Rats; Rats, Sprague-Dawley; Roscovitine; Time Factors; Tubulin | 2003 |
Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Inducing Factor; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cytochromes c; Cytosol; Down-Regulation; Enzyme Inhibitors; Flow Cytometry; Histone Deacetylase Inhibitors; HL-60 Cells; Humans; Hydroxamic Acids; Jurkat Cells; Leukemia; Membrane Potentials; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Protein Conformation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Purines; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Roscovitine; Time Factors; U937 Cells; X-Linked Inhibitor of Apoptosis Protein | 2005 |
Roscovitine inhibits extrusion of second polar body and induces apoptosis in rat eggs cultured in vitro.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cyclin B1; Cyclin-Dependent Kinases; Cytochromes c; Female; Metaphase; Ovum; Phosphorylation; Polar Bodies; Purines; Rats; Roscovitine; Tumor Suppressor Protein p53 | 2015 |